Life Science Company News

Aleafia Health Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-on

TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, today announced the expansion of its trailblazing cannabis wellness brand Noon & Night with the launch of the first of its kind CBD Freshly Minted Roll-on. The peppermint-scented roll-on is designed to provide a soothing, aromatic experience for cannabis consumers and patients through local application on the hairline, neck, forehead and shoulders.

“Noon & Night and our first to market Freshly Minted Roll-on are perfectly positioned to capitalize on the clear and growing demand for CBD-dominant wellness products in formats that are familiar to both cannabis aficionados and beginners,” said Aleafia Health CEO Geoffrey Benic. “The early market leadership of our wellness portfolio speaks to our team’s growing reputation for innovative product development. Our broader product portfolio strategy is paying dividends, with our strongest quarter in adult-use sales already achieved.”

On June 10, 2021, Mr. Benic made an additional purchase of the Company’s common shares on the public market, for a total balance of 357,000 common shares, all acquired using personal funds.

“We continue to execute upon our stated goal of bringing high-margin cannabis products to market, and delivering value to shareholders, patients and consumers.”

Designed and produced at Aleafia Health’s product innovation centre in Paris, Ont., the roll-on discretely fits in your palm and contains a curated blend of essential oils including peppermint, lavender, vetiver and eucalyptus, along with 200 mg of CBD.

Freshly Minted Roll-on continues the expansion of the Company’s highly differentiated Noon & Night brand, which already features the first of its kind Omega CBD Soft Gels and Lavender Fizz Bath Bombs. The category leading bath bombs have ranked first in both sales and units sold in the Bath & Shower category since May 1, according to data from the Ontario Cannabis Store.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com 
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/52e8b43d-0ac6-49fb-bb27-baeede6cf6ba


By: GlobenewsWire - 14 Jun 2021
Back to overview

Enhance your business development with Biotechgate